Replies to post #4119 on BioCryst Pharmaceuticals,Inc. (BCRX)

[agribusiness72]

Interesting article with the below being very important. Other than the bidaskclub, whoever the hell they are, positive analysts price points.

A number of research analysts have weighed in on BCRX shares. Piper Sandler reissued a “buy” rating and issued a $10.00 target price on shares of BioCryst Pharmaceuticals in a report on Monday, June 8th. HC Wainwright reissued a “buy” rating and issued a $13.00 target price on shares of BioCryst Pharmaceuticals in a report on Friday, August 7th. Royal Bank of Canada reissued a “hold” rating and issued a $4.50 target price on shares of BioCryst Pharmaceuticals in a report on Friday, August 28th. BidaskClub downgraded BioCryst Pharmaceuticals from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 25th. Finally, JMP Securities raised their price objective on BioCryst Pharmaceuticals from $10.00 to $11.00 and gave the stock an “outperform” rating in a research note on Friday, June 26th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $7.71.